Yesterday's PR: $NEWC appointing $CBIS president as scientific advisor will enable them to further CS-S/BCC-1 studies in Columbia instead of FDA route. Impressive
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.